Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
The American Journal of Pathology|October 15, 2013
IFN-γ-driven intratumoral microenvironment exhibits superior prognostic effect compared with an IFN-α-driven microenvironment in patients with colon carcinomaSandra Grenz, Elisabeth Naschberger, Susanne Merkel, et al.
Gut|April 4, 2015
Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancerElise Punkenburg, Tina Vogler, Maike Büttner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 yearsRolf Sauer, Torsten Liersch, Susanne Merkel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2014
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trialEmmanouil Fokas, Torsten Liersch, Rainer Fietkau, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2014
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trialHenriette Golcher, Thomas B Brunner, Helmut Witzigmann, et al.
Journal of Cancer Research and Clinical Oncology|July 19, 2019
Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cellsJulian Böhm, Julienne Kathrin Muenzner, Aylin Caliskan, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 13, 2012
Palliative treatment of colorectal cancer in Germany: cost of care and quality of lifeMartin Emmert, Katharina Pohl-Dernick, Axel Wein, et al.
The Journal of Pathology|November 11, 2024
AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomesYongsong Yong, Richard Demmler, Bisan Abdalfatah Zohud, et al.
Pageof 13